<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20250408082235&amp;utm_medium=rss
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;utm_campaign=pubmed-2&amp;v=2.18.0.post9+e462414&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_source=Chrome&amp;ff=20250408082235&amp;utm_medium=rss" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Tue, 08 Apr 2025 12:22:37 +0000</lastbuilddate>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196897/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehae812. doi: 10.1093/eurheartj/ehae812. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196897/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40196897</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae812>10.1093/eurheartj/ehae812</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196897</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Guang Xiong</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Post-capillary pulmonary hypertension in heart failure: addressing statistical and methodological issues in research</dc:title>
<dc:identifier>pmid:40196897</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae812</dc:identifier>
</item>
<item>
<title>Cardiovascular disease in chronic kidney disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196891/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients. This association likely reflects the involvement of several pathophysiological mechanisms, including shared risk factors (e.g. diabetes and hypertension), as well as other factors...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehaf167. doi: 10.1093/eurheartj/ehaf167. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Individuals with chronic kidney disease (CKD) exhibit an increased risk for the development of cardiovascular disease (CVD) with its manifestations coronary artery disease, stroke, heart failure, arrhythmias, and sudden cardiac death. The presence of both, CVD and CKD has a major impact on the prognosis of patients. This association likely reflects the involvement of several pathophysiological mechanisms, including shared risk factors (e.g. diabetes and hypertension), as well as other factors such as inflammation, anaemia, volume overload, and the presence of uraemic toxins. Identifying and characterizing CKD is crucial for appropriate CVD risk prediction. Mitigating CVD risk in patients with CKD mandates a multidisciplinary approach involving cardiologists, nephrologists, and other health care professionals. The present State-of-the-Art Review addresses the current understanding on the pathophysiological link between CVD and CKD, clinical implications and challenges in the treatment of these patients.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196891/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40196891</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf167>10.1093/eurheartj/ehaf167</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196891</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Katharina Marx-Schütt</dc:creator>
<dc:creator>David Z I Cherney</dc:creator>
<dc:creator>Joachim Jankowski</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Massimo Nardone</dc:creator>
<dc:creator>Nikolaus Marx</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Cardiovascular disease in chronic kidney disease</dc:title>
<dc:identifier>pmid:40196891</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf167</dc:identifier>
</item>
<item>
<title>Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of « hasard »</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40196886/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 8:ehae814. doi: 10.1093/eurheartj/ehae814. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40196886/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40196886</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae814>10.1093/eurheartj/ehae814</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40196886</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Charles Fauvel</dc:creator>
<dc:creator>Nicolas Lamblin</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Post-capillary Pulmonary Hypertension in Heart Failure is associated with higher mortality and morbidity risk: not just a matter of « hasard »</dc:title>
<dc:identifier>pmid:40196886</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae814</dc:identifier>
</item>
<item>
<title>Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40195566/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Irreversible cardiac fibrosis, cardiomyocyte death and chronic cardiac dysfunction after myocardial infarction pose a substantial global health-care challenge, with no curative treatments available. To regenerate the injured heart, cardiomyocytes must proliferate to replace lost myocardial tissue - a capability that adult mammals have largely forfeited to adapt to the demanding conditions of life. Using various preclinical models, our understanding of cardiomyocyte proliferation has progressed...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Apr 7. doi: 10.1038/s41569-025-01145-y. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Irreversible cardiac fibrosis, cardiomyocyte death and chronic cardiac dysfunction after myocardial infarction pose a substantial global health-care challenge, with no curative treatments available. To regenerate the injured heart, cardiomyocytes must proliferate to replace lost myocardial tissue - a capability that adult mammals have largely forfeited to adapt to the demanding conditions of life. Using various preclinical models, our understanding of cardiomyocyte proliferation has progressed remarkably, leading to the successful reactivation of cell cycle induction in adult animals, with functional recovery after cardiac injury. Central to this success is the targeting of key pathways and structures that drive cardiomyocyte maturation after birth - nucleation and ploidy, sarcomere structure, developmental signalling, chromatin and epigenetic regulation, the microenvironment and metabolic maturation - forming a complex regulatory framework that allows efficient cellular contraction but restricts cardiomyocyte proliferation. In this Review, we explore the molecular pathways underlying these core mechanisms and how their manipulation can reactivate the cell cycle in cardiomyocytes, potentially contributing to cardiac repair.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40195566/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40195566</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01145-y>10.1038/s41569-025-01145-y</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40195566</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Tim Koopmans</dc:creator>
<dc:creator>Eva van Rooij</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>Molecular gatekeepers of endogenous adult mammalian cardiomyocyte proliferation</dc:title>
<dc:identifier>pmid:40195566</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01145-y</dc:identifier>
</item>
<item>
<title>A turning point in cardiac remodelling in obesity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40195565/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Nat Rev Cardiol. 2025 Apr 7. doi: 10.1038/s41569-025-01154-x. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40195565/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40195565</a> | DOI:<a href=https://doi.org/10.1038/s41569-025-01154-x>10.1038/s41569-025-01154-x</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40195565</guid>
<pubDate>Tue, 08 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Mariella R Huaman</dc:creator>
<dc:creator>Carlos J Toro-Huamanchumo</dc:creator>
<dc:date>2025-04-08</dc:date>
<dc:source>Nature reviews. Cardiology</dc:source>
<dc:title>A turning point in cardiac remodelling in obesity</dc:title>
<dc:identifier>pmid:40195565</dc:identifier>
<dc:identifier>doi:10.1038/s41569-025-01154-x</dc:identifier>
</item>
<item>
<title>Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193543/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e921. doi: 10.1161/CIR.0000000000001331. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193543/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193543</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001331>10.1161/CIR.0000000000001331</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193543</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Jason Hong</dc:creator>
<dc:creator>Lejla Medzikovic</dc:creator>
<dc:creator>Wasila Sun</dc:creator>
<dc:creator>Brenda Wong</dc:creator>
<dc:creator>Grégoire Ruffenach</dc:creator>
<dc:creator>Christopher J Rhodes</dc:creator>
<dc:creator>Adam Brownstein</dc:creator>
<dc:creator>Lloyd L Liang</dc:creator>
<dc:creator>Laila Aryan</dc:creator>
<dc:creator>Min Li</dc:creator>
<dc:creator>Arjun Vadgama</dc:creator>
<dc:creator>Zeyneb Kurt</dc:creator>
<dc:creator>Tae-Hwi Schwantes-An</dc:creator>
<dc:creator>Elizabeth A Mickler</dc:creator>
<dc:creator>Stefan Gräf</dc:creator>
<dc:creator>Mélanie Eyries</dc:creator>
<dc:creator>Katie A Lutz</dc:creator>
<dc:creator>Michael W Pauciulo</dc:creator>
<dc:creator>Richard C Trembath</dc:creator>
<dc:creator>Frédéric Perros</dc:creator>
<dc:creator>David Montani</dc:creator>
<dc:creator>Nicholas W Morrell</dc:creator>
<dc:creator>Florent Soubrier</dc:creator>
<dc:creator>Martin R Wilkins</dc:creator>
<dc:creator>William C Nichols</dc:creator>
<dc:creator>Micheala A Aldred</dc:creator>
<dc:creator>Ankit A Desai</dc:creator>
<dc:creator>David-Alexandre Trégouët</dc:creator>
<dc:creator>Soban Umar</dc:creator>
<dc:creator>Rajan Saggar</dc:creator>
<dc:creator>Richard Channick</dc:creator>
<dc:creator>Rubin M Tuder</dc:creator>
<dc:creator>Mark W Geraci</dc:creator>
<dc:creator>Robert S Stearman</dc:creator>
<dc:creator>Xia Yang</dc:creator>
<dc:creator>Mansoureh Eghbali</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Integrative Multiomics in the Lung Reveals a Protective Role of Asporin in Pulmonary Arterial Hypertension</dc:title>
<dc:identifier>pmid:40193543</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001331</dc:identifier>
</item>
<item>
<title>Predicting Cardiovascular Risk With Use of Various Tobacco Products</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193542/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):1006-1008. doi: 10.1161/CIRCULATIONAHA.125.073894. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193542/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193542</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073894>10.1161/CIRCULATIONAHA.125.073894</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193542</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Neal L Benowitz</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Predicting Cardiovascular Risk With Use of Various Tobacco Products</dc:title>
<dc:identifier>pmid:40193542</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073894</dc:identifier>
</item>
<item>
<title>Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193541/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e919. doi: 10.1161/CIR.0000000000001327. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193541/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193541</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001327>10.1161/CIR.0000000000001327</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193541</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Joseph C Wu</dc:creator>
<dc:creator>Donna K Arnett</dc:creator>
<dc:creator>Ivor J Benjamin</dc:creator>
<dc:creator>Mark A Creager</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Joseph A Hill</dc:creator>
<dc:creator>P Michael Ho</dc:creator>
<dc:creator>Steven R Houser</dc:creator>
<dc:creator>Stephanie Scarmo</dc:creator>
<dc:creator>Svati H Shah</dc:creator>
<dc:creator>Gordon F Tomaselli</dc:creator>
<dc:creator>American Heart Association</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Principles for the Future of Biomedical Research in the United States and Optimizing the National Institutes of Health: A Presidential Advisory From the American Heart Association</dc:title>
<dc:identifier>pmid:40193541</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001327</dc:identifier>
</item>
<item>
<title>Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection Fraction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193540/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):990-992. doi: 10.1161/CIRCULATIONAHA.125.073788. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193540/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193540</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.125.073788>10.1161/CIRCULATIONAHA.125.073788</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193540</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Torbjørn Omland</dc:creator>
<dc:creator>Nicholas L Mills</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Natriuretic Peptides for the Diagnosis of Heart Failure With Preserved Ejection Fraction</dc:title>
<dc:identifier>pmid:40193540</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.125.073788</dc:identifier>
</item>
<item>
<title>Correction to: Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193539/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e920. doi: 10.1161/CIR.0000000000001332. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193539/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193539</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001332>10.1161/CIR.0000000000001332</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193539</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Sheng Zhang</dc:creator>
<dc:creator>Yunkai Zhang</dc:creator>
<dc:creator>Xuewen Duan</dc:creator>
<dc:creator>Bo Wang</dc:creator>
<dc:creator>Zhenzhen Zhan</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Targeting NPM1 Epigenetically Promotes Postinfarction Cardiac Repair by Reprogramming Reparative Macrophage Metabolism</dc:title>
<dc:identifier>pmid:40193539</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001332</dc:identifier>
</item>
<item>
<title>Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193538/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e922. doi: 10.1161/CIR.0000000000001322. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193538/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193538</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001322>10.1161/CIR.0000000000001322</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193538</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Zhiqi Yao</dc:creator>
<dc:creator>Erfan Tasdighi</dc:creator>
<dc:creator>Zeina A Dardari</dc:creator>
<dc:creator>Kunal K Jha</dc:creator>
<dc:creator>Ngozi Osuji</dc:creator>
<dc:creator>Tanuja Rajan</dc:creator>
<dc:creator>Ellen Boakye</dc:creator>
<dc:creator>Carlos J Rodriguez</dc:creator>
<dc:creator>Kunihiro Matsushita</dc:creator>
<dc:creator>Eleanor M Simonsick</dc:creator>
<dc:creator>Joao A C Lima</dc:creator>
<dc:creator>Rachel Widome</dc:creator>
<dc:creator>Debbie L Cohen</dc:creator>
<dc:creator>Lawrence J Appel</dc:creator>
<dc:creator>Amit Khera</dc:creator>
<dc:creator>Michael E Hall</dc:creator>
<dc:creator>Suzanne Judd</dc:creator>
<dc:creator>Shelley A Cole</dc:creator>
<dc:creator>Ramachandran S Vasan</dc:creator>
<dc:creator>Emelia J Benjamin</dc:creator>
<dc:creator>Aruni Bhatnagar</dc:creator>
<dc:creator>Andrew P DeFilippis</dc:creator>
<dc:creator>Michael J Blaha</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: Differential Associations of Cigar, Pipe, and Smokeless Tobacco Use Versus Combustible Cigarette Use With Subclinical Markers of Inflammation, Thrombosis, and Atherosclerosis: The Cross-Cohort Collaboration-Tobacco Working Group</dc:title>
<dc:identifier>pmid:40193538</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001322</dc:identifier>
</item>
<item>
<title>Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193537/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):e918. doi: 10.1161/CIR.0000000000001329. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193537/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193537</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001329>10.1161/CIR.0000000000001329</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193537</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Heather L Gornik</dc:creator>
<dc:creator>Herbert D Aronow</dc:creator>
<dc:creator>Philip P Goodney</dc:creator>
<dc:creator>Shipra Arya</dc:creator>
<dc:creator>Luke Packard Brewster</dc:creator>
<dc:creator>Lori Byrd</dc:creator>
<dc:creator>Venita Chandra</dc:creator>
<dc:creator>Douglas E Drachman</dc:creator>
<dc:creator>Jennifer M Eaves</dc:creator>
<dc:creator>Jonathan K Ehrman</dc:creator>
<dc:creator>John N Evans</dc:creator>
<dc:creator>Thomas S D Getchius</dc:creator>
<dc:creator>J Antonio Gutiérrez</dc:creator>
<dc:creator>Beau M Hawkins</dc:creator>
<dc:creator>Connie N Hess</dc:creator>
<dc:creator>Karen J Ho</dc:creator>
<dc:creator>W Schuyler Jones</dc:creator>
<dc:creator>Esther S H Kim</dc:creator>
<dc:creator>Scott Kinlay</dc:creator>
<dc:creator>Lee Kirksey</dc:creator>
<dc:creator>Debra Kohlman-Trigoboff</dc:creator>
<dc:creator>Chandler A Long</dc:creator>
<dc:creator>Amy West Pollak</dc:creator>
<dc:creator>Saher S Sabri</dc:creator>
<dc:creator>Lawrence B Sadwin</dc:creator>
<dc:creator>Eric A Secemsky</dc:creator>
<dc:creator>Maya Serhal</dc:creator>
<dc:creator>Mehdi H Shishehbor</dc:creator>
<dc:creator>Diane Treat-Jacobson</dc:creator>
<dc:creator>Luke R Wilkins</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Correction to: 2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines</dc:title>
<dc:identifier>pmid:40193537</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001329</dc:identifier>
</item>
<item>
<title>Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193536/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):1047-1050. doi: 10.1161/CIRCULATIONAHA.124.071269. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193536/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193536</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071269>10.1161/CIRCULATIONAHA.124.071269</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193536</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>P Gabriel Steg</dc:creator>
<dc:creator>Michael Szarek</dc:creator>
<dc:creator>J Wouter Jukema</dc:creator>
<dc:creator>Deepak L Bhatt</dc:creator>
<dc:creator>Vera A Bittner</dc:creator>
<dc:creator>Rafael Diaz</dc:creator>
<dc:creator>Sergio Fazio</dc:creator>
<dc:creator>Geneviève Garon</dc:creator>
<dc:creator>Shaun G Goodman</dc:creator>
<dc:creator>Robert A Harrington</dc:creator>
<dc:creator>Harvey D White</dc:creator>
<dc:creator>Andreas M Zeiher</dc:creator>
<dc:creator>Gregory G Schwartz</dc:creator>
<dc:creator>ODYSSEY OUTCOMES Investigators</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Relation of Low-Density Lipoprotein Cholesterol, High-Sensitivity C-Reactive Protein, and Lipoprotein(a) Each to Future Cardiovascular Events and Death After Acute Coronary Syndrome on High-Intensity Statin Therapy: An Analysis of the Placebo Arm of ODYSSEY OUTCOMES</dc:title>
<dc:identifier>pmid:40193536</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071269</dc:identifier>
</item>
<item>
<title>&lt;em>;Circulation&lt;/em>; Global Rounds: Denmark</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40193535/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 8;151(14):973-975. doi: 10.1161/CIRCULATIONAHA.124.071545. Epub 2025 Apr 7.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40193535/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40193535</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071545>10.1161/CIRCULATIONAHA.124.071545</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40193535</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Caroline Espersen</dc:creator>
<dc:creator>Anne Marie Reimer Jensen</dc:creator>
<dc:creator>Tor Biering-Sørensen</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>&lt;em>;Circulation&lt;/em>; Global Rounds: Denmark</dc:title>
<dc:identifier>pmid:40193535</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071545</dc:identifier>
</item>
<item>
<title>Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40191995/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2025 Apr 7;46(14):1277-1280. doi: 10.1093/eurheartj/ehaf163.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40191995/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40191995</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehaf163>10.1093/eurheartj/ehaf163</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40191995</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on blood pressure: sex-specific association with atrial fibrillation, role of gliflozins in hypertension, and new therapeutic targets in hypertension and orthostatic hypotension</dc:title>
<dc:identifier>pmid:40191995</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehaf163</dc:identifier>
</item>
<item>
<title>Racial Disparities in Long-Term Outcomes After Endovascular Aortic Aneurysm Repair in Black and White Medicare Beneficiaries</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40190277/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Black patients demonstrated increased risk of late aortic-related events after endovascular aortic aneurysm repair after accounting for the competing risk of death and controlling for baseline covariates. Further investigation into preoperative medical management and barriers to postoperative health care access is necessary to further elucidate underlying mechanisms for the observed disparities.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 7. doi: 10.1161/CIRCULATIONAHA.124.072018. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Despite reported racial disparities between Black and White adults in short-term outcomes after abdominal aortic aneurysmal intervention, there is a paucity of literature aimed at understanding long-term disparities. The present study aims to characterize racial disparities in long-term outcomes, perioperative outcomes, and health care use after endovascular aortic aneurysm repair.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: We conducted a retrospective cohort study from 2011 to 2019 with outcome assessment through 2020. Using a 100% sample of national Medicare data, we identified beneficiaries ≥66 years of age who underwent intact infrarenal endovascular aortic aneurysm repair. The primary outcome was a composite of endovascular or open aortic reintervention, late aneurysm rupture, and all-cause mortality. Secondary outcomes included other reinterventions, perioperative outcomes, and annual rates of health care use.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: A cohort of 107 636 Black (3.9%) and White (96.1%) beneficiaries was identified. The cumulative incidence of the primary outcome was 72.9% (95% CI, 71.8%-73.9%) in White patients versus 80.0% (95% CI, 76.4-83.0) in Black patients (<i>P</i>&lt;0.0001). The adjusted hazard of the primary outcome was not significantly different between Black and White adults (adjusted hazard ratio [HR] 1.04 [95% CI, 0.99-1.09]); however, when death was treated as a competing risk, a significantly higher hazard for the composite outcome was observed for Black patients (subdistribution HR, 1.56 [95% CI, 1.39-1.76]). Components of the primary outcome were also greater among Black compared with White patients. Black patients had higher rates of medical complications in the perioperative period, including acute renal failure (subdistribution HR, 1.18 [95% CI, 1.01-1.38]), dialysis initiation (subdistribution HR, 2.75 [95% CI, 2.03-3.7]), and deep vein thrombosis (subdistribution HR, 1.54 [95% CI, 1.05-2.26]). Black patients had lower rates of vascular office visits after intervention (adjusted rate ratio, 0.96 [95% CI, 0.93-0.99]) but higher rates of emergency department visits (adjusted rate ratio, 1.05 [95% CI, 1.02-1.09]) and hospital readmissions (adjusted rate ratio, 1.13 [95% CI, 1.08-1.18]).</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Black patients demonstrated increased risk of late aortic-related events after endovascular aortic aneurysm repair after accounting for the competing risk of death and controlling for baseline covariates. Further investigation into preoperative medical management and barriers to postoperative health care access is necessary to further elucidate underlying mechanisms for the observed disparities.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40190277/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40190277</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.072018>10.1161/CIRCULATIONAHA.124.072018</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40190277</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Abena Appah-Sampong</dc:creator>
<dc:creator>Christina Marcaccio</dc:creator>
<dc:creator>Siling Li</dc:creator>
<dc:creator>Yang Song</dc:creator>
<dc:creator>Mohamad A Hussain</dc:creator>
<dc:creator>Robert Yeh</dc:creator>
<dc:creator>Marc L Schermerhorn</dc:creator>
<dc:creator>Eric A Secemsky</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Racial Disparities in Long-Term Outcomes After Endovascular Aortic Aneurysm Repair in Black and White Medicare Beneficiaries</dc:title>
<dc:identifier>pmid:40190277</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.072018</dc:identifier>
</item>
<item>
<title>Metabolic Coordination Structures Contribute to Diabetic Myocardial Dysfunction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40190276/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Our findings demonstrated that ACBP mediates the bidirectional regulation of cardiomyocyte metabolic and structural associations and identified a promising therapeutic target for ameliorating cardiac dysfunction in patients with T2DM.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Circ Res. 2025 Apr 7. doi: 10.1161/CIRCRESAHA.124.326044. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND: Individuals with diabetes are susceptible to cardiac dysfunction and heart failure, potentially resulting in mortality. Metabolic disorders frequently occur in patients with diabetes, and diabetes usually leads to remodeling of heart structure and cardiac dysfunction. However, the contribution and underlying mechanisms of metabolic and structural coupling in diabetic cardiac dysfunction remain elusive.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Two mouse models of type 2 diabetes (T2DM) were used to assess alterations in glucose/lipid metabolism and cardiac structure. The potential metabolic-structural coupling molecule ACBP (acyl-coenzyme A-binding protein) was screened from 4 published datasets of T2DM-associated heart disease. In vivo loss-of-function and gain-of-function approaches were used to investigate the role of ACBP in diabetic cardiac dysfunction. The underlying mechanisms of metabolic and structural coupling were investigated by stable-isotope tracing metabolomics, coimmunoprecipitation coupled with mass spectrometry, and chromatin immunoprecipitation sequencing.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Diabetic mouse hearts exhibit enhanced lipid metabolism and impaired ultrastructure with marked cardiac systolic and diastolic dysfunction. Analysis of 4 T2DM public datasets revealed that <i>Acbp</i> was a significant lipid metabolism gene whose expression was upregulated. Consistently, ACBP expression levels were markedly elevated in the hearts of patients with diabetes and diabetic mice. Moreover, we constructed cardiomyocyte-specific <i>Acbp</i> knockout mice that exhibited attenuation of T2DM-induced cardiac remodeling and cardiac dysfunction, including attenuation of cardiac hypertrophy, fibrosis, ultrastructural damage, and enhanced cardiomyocyte contractility and cardiac function. Conversely, cardiac-specific <i>Acbp</i> overexpression via adeno-associated virus type 9, which encodes <i>Acbp</i> under the cTnT (cardiac troponin T) promoter, recapitulated cardiac dysfunction. Mechanistically, cardiac-specific <i>Acbp</i> knockout enhances glucose utilization in diabetic cardiomyocytes, suggesting a potential compensatory mechanism for insufficient ATP levels, highlighting its metabolic role. In addition, combined with mass spectrometry analysis revealed that ACBP binds MyBPC3 (myosin-binding protein C3) in T2DM individuals, which potentially prevents MyBPC3 from assisting the formation of cross-bridge structures between myosin and actin, thereby impairing myocardial contraction. Importantly, chromatin immunoprecipitation sequencing revealed that peroxisome proliferator-activated receptor γ regulates the transcriptional activity of <i>Acbp</i>.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Our findings demonstrated that ACBP mediates the bidirectional regulation of cardiomyocyte metabolic and structural associations and identified a promising therapeutic target for ameliorating cardiac dysfunction in patients with T2DM.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40190276/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40190276</a> | DOI:<a href=https://doi.org/10.1161/CIRCRESAHA.124.326044>10.1161/CIRCRESAHA.124.326044</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40190276</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Teng Wu</dc:creator>
<dc:creator>Tongsheng Huang</dc:creator>
<dc:creator>Honglin Ren</dc:creator>
<dc:creator>Conghui Shen</dc:creator>
<dc:creator>Jiang Qian</dc:creator>
<dc:creator>Xinlu Fu</dc:creator>
<dc:creator>Shangyuan Liu</dc:creator>
<dc:creator>Chengshu Xie</dc:creator>
<dc:creator>Xi Lin</dc:creator>
<dc:creator>Junhong Wan</dc:creator>
<dc:creator>Shijie Xiong</dc:creator>
<dc:creator>Yuanjun Ji</dc:creator>
<dc:creator>Mengying Liu</dc:creator>
<dc:creator>Huiting Zheng</dc:creator>
<dc:creator>Ting Liang</dc:creator>
<dc:creator>Wenyi Liu</dc:creator>
<dc:creator>Yan Zou</dc:creator>
<dc:creator>Jingwei Li</dc:creator>
<dc:creator>Maoquan Yang</dc:creator>
<dc:creator>Zeyi Song</dc:creator>
<dc:creator>Peixuan Lan</dc:creator>
<dc:creator>Xinghui Li</dc:creator>
<dc:creator>Yandi Wu</dc:creator>
<dc:creator>Ming Yang</dc:creator>
<dc:creator>Hui Li</dc:creator>
<dc:creator>Xuezhe Huang</dc:creator>
<dc:creator>Hui Chen</dc:creator>
<dc:creator>Jing Tan</dc:creator>
<dc:creator>Weibin Cai</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation research</dc:source>
<dc:title>Metabolic Coordination Structures Contribute to Diabetic Myocardial Dysfunction</dc:title>
<dc:identifier>pmid:40190276</dc:identifier>
<dc:identifier>doi:10.1161/CIRCRESAHA.124.326044</dc:identifier>
</item>
<item>
<title>Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40190270/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Populations most affected by cardiovascular health disparities, including underrepresented populations with lower socioeconomic status, people with disabilities, and those living in underserved rural communities, are disproportionately exposed to adverse social determinants of health. Specifically, economic instability and suboptimal living conditions within the neighborhood and built environment directly determine access to resources and opportunities for healthful behaviors. In this scientific...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2025 Apr 7. doi: 10.1161/CIR.0000000000001314. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Populations most affected by cardiovascular health disparities, including underrepresented populations with lower socioeconomic status, people with disabilities, and those living in underserved rural communities, are disproportionately exposed to adverse social determinants of health. Specifically, economic instability and suboptimal living conditions within the neighborhood and built environment directly determine access to resources and opportunities for healthful behaviors. In this scientific statement, we examined the technology-enabled interventions that address cardiovascular health behaviors from adolescence to adulthood in populations most affected by health disparities. We used a broad definition of technology, including wearables, applications, and telehealth, for behavior tracking. Aligning with Life's Essential 8, we focused on interventions targeting behavior change related to physical activity, sedentary time, dietary intake, tobacco cessation, and sleep health to improve cardiovascular health. The digital determinants of health are important adjuncts to the social determinants and operate at the individual, interpersonal, community, and societal levels. The digital determinants of health include the impact of digital technologies (eg, wearables, telemedicine) across health outcomes. Evidence of effective interventions using technology to improve cardiovascular health through positive behavior change is critical for preventing cardiovascular disease events. Stronger evidence is needed to inform and implement effective approaches that are scalable and cost-effective across communities and health care institutions to advance digital equity in cardiovascular health. Dissemination of digital solutions to improve cardiovascular health in communities or across health care systems must ensure effective, feasible, available, and affordable solutions for populations most in need.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40190270/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40190270</a> | DOI:<a href=https://doi.org/10.1161/CIR.0000000000001314>10.1161/CIR.0000000000001314</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40190270</guid>
<pubDate>Mon, 07 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Tiffany M Powell-Wiley</dc:creator>
<dc:creator>LaPrincess C Brewer</dc:creator>
<dc:creator>Lora E Burke</dc:creator>
<dc:creator>Rosalba Hernandez</dc:creator>
<dc:creator>Jill Landsbaugh Kaar</dc:creator>
<dc:creator>Maura Kepper</dc:creator>
<dc:creator>Christopher E Kline</dc:creator>
<dc:creator>Keila N Lopez</dc:creator>
<dc:creator>Shamarial Roberson</dc:creator>
<dc:creator>Colleen K Spees</dc:creator>
<dc:creator>Gerald J Jerome</dc:creator>
<dc:creator>American Heart Association Council on Lifestyle and Cardiometabolic Health; Council on Cardiovascular and Stroke Nursing; Council on Peripheral Vascular Disease; and Council on Quality of Care and Outcomes Research</dc:creator>
<dc:date>2025-04-07</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Role of Technology in Promoting Heart Healthy Behavior Change to Increase Equity in Optimal Cardiovascular Health: A Scientific Statement From the American Heart Association</dc:title>
<dc:identifier>pmid:40190270</dc:identifier>
<dc:identifier>doi:10.1161/CIR.0000000000001314</dc:identifier>
</item>
<item>
<title>Channel synapse mediates neurotransmission of airway protective chemoreflexes</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40187347/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Neural reflexes to chemicals in the throat protect the airway from aspiration and infection. Mechanistic understanding of these reflexes remains premature, exemplified by chronic cough-a sensitized cough reflex-being a prevalent unmet clinical need. Here, in mice, a whole-body search for channel synapses-featuring CALHM1/3 channel-mediated neurotransmitter release-and single-cell transcriptomics uncovered subclasses of the Pou2f3^(+) chemosensory cell family in the throat communicating with...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Apr 2:S0092-8674(25)00280-6. doi: 10.1016/j.cell.2025.03.007. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Neural reflexes to chemicals in the throat protect the airway from aspiration and infection. Mechanistic understanding of these reflexes remains premature, exemplified by chronic cough-a sensitized cough reflex-being a prevalent unmet clinical need. Here, in mice, a whole-body search for channel synapses-featuring CALHM1/3 channel-mediated neurotransmitter release-and single-cell transcriptomics uncovered subclasses of the Pou2f3<sup>+</sup> chemosensory cell family in the throat communicating with vagal neurons via this synapse. They express G protein-coupled receptors (GPCRs) for noxious chemicals, T2Rs, which upon stimulation trigger swallow and cough-like expulsive reflexes in the hypopharynx and larynx, respectively. These reflexes were abolished by Calhm3 and Pou2f3 knockout and could be triggered by targeted optogenetic stimulation. Furthermore, aeroallergen exposure augmented CALHM3-dependent expulsive reflex. This study identifies Pou2f3<sup>+</sup> epithelial cells with channel synapses as chemosensory end organs of airway protective reflexes and sites of their hyperresponsiveness, advancing mechanistic understanding of airway defense programs with distinct therapeutic potential.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40187347/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40187347</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.03.007>10.1016/j.cell.2025.03.007</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40187347</guid>
<pubDate>Sat, 05 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Shogo Soma</dc:creator>
<dc:creator>Norihito Hayatsu</dc:creator>
<dc:creator>Kengo Nomura</dc:creator>
<dc:creator>Mark W Sherwood</dc:creator>
<dc:creator>Tatsuro Murakami</dc:creator>
<dc:creator>Yoichiro Sugiyama</dc:creator>
<dc:creator>Naofumi Suematsu</dc:creator>
<dc:creator>Takanori Aoki</dc:creator>
<dc:creator>Yu Yamada</dc:creator>
<dc:creator>Moe Asayama</dc:creator>
<dc:creator>Mami Kaneko</dc:creator>
<dc:creator>Kento Ohbayashi</dc:creator>
<dc:creator>Misa Arizono</dc:creator>
<dc:creator>Masato Ohtsuka</dc:creator>
<dc:creator>Shun Hamada</dc:creator>
<dc:creator>Ichiro Matsumoto</dc:creator>
<dc:creator>Yusaku Iwasaki</dc:creator>
<dc:creator>Nobuhiko Ohno</dc:creator>
<dc:creator>Yasushi Okazaki</dc:creator>
<dc:creator>Akiyuki Taruno</dc:creator>
<dc:date>2025-04-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Channel synapse mediates neurotransmission of airway protective chemoreflexes</dc:title>
<dc:identifier>pmid:40187347</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.03.007</dc:identifier>
</item>
<item>
<title>Conserved genetic basis for microbial colonization of the gut</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40187346/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Despite the fundamental importance of gut microbes, the genetic basis of their colonization remains largely unexplored. Here, by applying cross-species genotype-habitat association at the tree-of-life scale, we identify conserved microbial gene modules associated with gut colonization. Across thousands of species, we discovered 79 taxonomically diverse putative colonization factors organized into operonic and non-operonic modules. They include previously characterized colonization pathways such...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Apr 2:S0092-8674(25)00283-1. doi: 10.1016/j.cell.2025.03.010. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Despite the fundamental importance of gut microbes, the genetic basis of their colonization remains largely unexplored. Here, by applying cross-species genotype-habitat association at the tree-of-life scale, we identify conserved microbial gene modules associated with gut colonization. Across thousands of species, we discovered 79 taxonomically diverse putative colonization factors organized into operonic and non-operonic modules. They include previously characterized colonization pathways such as autoinducer-2 biosynthesis and novel processes including tRNA modification and translation. In vivo functional validation revealed YigZ (IMPACT family) and tRNA hydroxylation protein-P (TrhP) are required for E. coli intestinal colonization. Overexpressing YigZ alone is sufficient to enhance colonization of the poorly colonizing MG1655 E. coli by >;100-fold. Moreover, natural allelic variations in YigZ impact inter-strain colonization efficiency. Our findings highlight the power of large-scale comparative genomics in revealing the genetic basis of microbial adaptations. These broadly conserved colonization factors may prove critical for understanding gastrointestinal (GI) dysbiosis and developing therapeutics.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40187346/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40187346</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.03.010>10.1016/j.cell.2025.03.010</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40187346</guid>
<pubDate>Sat, 05 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Menghan Liu</dc:creator>
<dc:creator>Sydney B Blattman</dc:creator>
<dc:creator>Mai Takahashi</dc:creator>
<dc:creator>Nandan Mandayam</dc:creator>
<dc:creator>Wenyan Jiang</dc:creator>
<dc:creator>Panos Oikonomou</dc:creator>
<dc:creator>Sohail F Tavazoie</dc:creator>
<dc:creator>Saeed Tavazoie</dc:creator>
<dc:date>2025-04-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Conserved genetic basis for microbial colonization of the gut</dc:title>
<dc:identifier>pmid:40187346</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.03.010</dc:identifier>
</item>
<item>
<title>Molecular basis for shifted receptor recognition by an encephalitic arbovirus</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/40187345/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20250408082235&amp;v=2.18.0.post9+e462414
      <description>Western equine encephalitis virus (WEEV) is an arbovirus that historically caused large outbreaks of encephalitis throughout the Americas. WEEV binds protocadherin 10 (PCDH10) as a receptor, and highly virulent ancestral WEEV strains also bind low-density lipoprotein receptor (LDLR)-related proteins. As WEEV declined as a human pathogen in North America over the past century, isolates have lost the ability to bind mammalian receptors while still recognizing avian receptors. To explain shifts in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Cell</b>. 2025 Apr 2:S0092-8674(25)00347-2. doi: 10.1016/j.cell.2025.03.029. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Western equine encephalitis virus (WEEV) is an arbovirus that historically caused large outbreaks of encephalitis throughout the Americas. WEEV binds protocadherin 10 (PCDH10) as a receptor, and highly virulent ancestral WEEV strains also bind low-density lipoprotein receptor (LDLR)-related proteins. As WEEV declined as a human pathogen in North America over the past century, isolates have lost the ability to bind mammalian receptors while still recognizing avian receptors. To explain shifts in receptor dependencies and assess the risk of WEEV re-emergence, we determined cryoelectron microscopy structures of WEEV bound to human PCDH10, avian PCDH10, and human very-low-density lipoprotein receptor (VLDLR). We show that one to three E2 glycoprotein substitutions are sufficient for a nonpathogenic strain to regain the ability to bind mammalian receptors. A soluble VLDLR fragment protects mice from lethal challenge by a virulent ancestral WEEV strain. Because WEEV recently re-emerged in South America after decades of inactivity, our findings have important implications for outbreak preparedness.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/40187345/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20250408082235&v=2.18.0.post9+e462414">40187345</a> | DOI:<a href=https://doi.org/10.1016/j.cell.2025.03.029>10.1016/j.cell.2025.03.029</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:40187345</guid>
<pubDate>Sat, 05 Apr 2025 06:00:00 -0400</pubDate>
<dc:creator>Xiaoyi Fan</dc:creator>
<dc:creator>Wanyu Li</dc:creator>
<dc:creator>Jessica Oros</dc:creator>
<dc:creator>Jessica A Plante</dc:creator>
<dc:creator>Brooke M Mitchell</dc:creator>
<dc:creator>Jesse S Plung</dc:creator>
<dc:creator>Himanish Basu</dc:creator>
<dc:creator>Sivapratha Nagappan-Chettiar</dc:creator>
<dc:creator>Joshua M Boeckers</dc:creator>
<dc:creator>Laurentia V Tjang</dc:creator>
<dc:creator>Colin J Mann</dc:creator>
<dc:creator>Vesna Brusic</dc:creator>
<dc:creator>Tierra K Buck</dc:creator>
<dc:creator>Haley Varnum</dc:creator>
<dc:creator>Pan Yang</dc:creator>
<dc:creator>Linzy M Malcolm</dc:creator>
<dc:creator>So Yoen Choi</dc:creator>
<dc:creator>William M de Souza</dc:creator>
<dc:creator>Isaac M Chiu</dc:creator>
<dc:creator>Hisashi Umemori</dc:creator>
<dc:creator>Scott C Weaver</dc:creator>
<dc:creator>Kenneth S Plante</dc:creator>
<dc:creator>Jonathan Abraham</dc:creator>
<dc:date>2025-04-05</dc:date>
<dc:source>Cell</dc:source>
<dc:title>Molecular basis for shifted receptor recognition by an encephalitic arbovirus</dc:title>
<dc:identifier>pmid:40187345</dc:identifier>
<dc:identifier>doi:10.1016/j.cell.2025.03.029</dc:identifier>
</item>





























</channel>
</rss>